NBP
NovaBridge Biosciences
1.40$
-0.4%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | -324.4% | – | – | – | – | |
| – | +312.5% | +132.0% | +48.0% | +47.5% | +86.9% | -98.3% | +571.3% | -88.0% | |
| – | -50.0% | +10,323.2% | +34.5% | +23.3% | -41.3% | -97.1% | -238.6% | – | |
| – | +487.4% | +25.6% | -230.2% | – | +39.9% | -106.7% | – | – | |
| – | -29.1% | -15.0% | -34.6% | +273.8% | +53.1% | -99.6% | +113.2% | -98.0% | |
| – | – | +2,136.4% | -195.0% | +260.2% | – | -123.5% | +822.1% | – | |
| – | – | – | – | – | – | – | – | – | |
| – | – | – | – | -100.0% | – | +181.3% | -71.8% | -100.0% | |
| – | – | – | – | – | – | +259.0% | – | – | |
| – | +95.1% | -89.7% | +2,153.0% | -82.7% | -92.9% | -119.5% | -70.4% | – | |
| – | +263.8% | -138.5% | – | -134.6% | – | – | – | – | |
| – | – | – | – | -335.7% | – | – | – | – |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.